MATTERHORN Trial Highlights the Transformative Potential of Durvalumab + FLOT in Gastric and GEJ Cancer Treatment Other 1 Min Read Author: Dr. Yelena Janjigian (on-camera comments) – Courtesy of ESMO.org The Matterhorn study, a significant phase three global research effort,…
Durvalumab + olaparib 45% Reduction Disease Progression in Endometrial – ESMO 2023 Cervical 2 Mins Read By. Shannon Westin, MDDate. October 27, 2023In the video interview, Shannon Westin, MD, discusses the key findings from the DUO-E…
Updates in Head and Neck Cancer [2023] Interview – Shirin Attarian, MD – MOASC Head and Neck 2 Mins Read Shirin Attarian, MD addresses the escalating incidence of head and neck cancer and highlights that most cases, particularly oropharyngeal cancers,…